Propensity score-matched comparison of survival outcomes between clear cell and non-clear cell renal cell carcinoma in cT1N0M0 disease.

Authors

Ryotaro Tomida, Yoshito Kusuhara, Marika Atagi, Fumiya Kadoriku, Tetsuhiro Yano, Mitsuki Nishiyama, Saki Kobayashi, Ryoei Minato, Keito Shiozaki, Kei Daizumoto, Yutaro Sasaki, Tomoya Fukawa, Kunihisa Yamaguchi, Yasuyo Yamamoto, Junya Furukawa

Published in

International journal of clinical oncology. Aug 03, 2026. Epub Aug 03, 2026.

Abstract

Non-clear cell renal cell carcinoma (nccRCC) is a rare and heterogeneous group of tumors, and data regarding its prognosis remain limited. This study primarily aimed to compare survival outcomes between clear cell RCC (ccRCC) and nccRCC, limited to papillary and chromophobe RCC, using propensity score matching (PSM). A secondary analysis evaluated prognostic differences among histological subtypes of nccRCC.
We retrospectively reviewed patients who underwent curative surgery for non-metastatic RCC between 2001 and 2023. Patients with cT1N0M0 ccRCC and nccRCC (papillary and chromophobe RCC) were matched at a 2:1 ratio using PSM. Recurrence-free survival (RFS), cancer-specific survival (CSS), and overall survival (OS) were compared overall and according to surgical procedure. A secondary analysis compared survival outcomes among histological subtypes of nccRCC.
The matched cohort included 100 patients with ccRCC and 50 with nccRCC. Five-year RFS, CSS, and OS were comparable between the groups (94.2% vs. 95.3%, P = 0.934; 100% vs. 95.3%, P = 0.564; and 96.9% vs. 100%, P = 0.573, respectively). Similar findings were observed in both radical and partial nephrectomy subgroups. In the secondary analysis, survival outcomes varied according to histological subtype among patients with nccRCC.
After adjustment for baseline characteristics, including surgical modality, survival outcomes were comparable between cT1N0M0 ccRCC and papillary or chromophobe RCC. Surgical modality did not appear to modify these outcomes. Prognosis differed according to histological subtype among patients with nccRCC, supporting individualized treatment strategies and follow-up protocols.

PMID:
42545669
Bibliographic data and abstract were imported from PubMed on 03 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.